--- title: "GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS" type: "News" locale: "en" url: "https://longbridge.com/en/news/293809527.md" description: "ClaimsFiler reminds investors who lost over $100,000 in GeneDx Holdings Corp. (WGS) shares between April 16, 2025, and May 4, 2026, to file lead plaintiff applications by August 3, 2026. The class action lawsuit alleges the company failed to disclose material information regarding missed revenue estimates, lowered guidance, and a $31.2 million impairment loss from the Fabric Genomics acquisition." datetime: "2026-07-25T02:29:08.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293809527.md) - [en](https://longbridge.com/en/news/293809527.md) - [zh-HK](https://longbridge.com/zh-HK/news/293809527.md) generator: "portal-rs" --- # GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS NEW ORLEANS, July 24, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until **August 3, 2026** to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NasdaqGS: WGS), if they purchased or otherwise acquired the Company's shares between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Connecticut. Get Help GeneDx investors should visit us at https://www.claimsfiler.com/cases/nasdaq-wgs/?prs=prn or call toll-free (833) 538-3604. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options. About the Lawsuit GeneDx and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. On May 4, 2026, the Company reported its financial results for the first quarter of fiscal year 2026, disclosing a drop in adjusted gross margin from 74% to 69%, that it had missed its revenue estimates for both its exome and genome lines, and lowered its guidance for full year revenue to $475 – $490 million, down from $540 – $550 million. The Company also disclosed a $31.2 million impairment loss attributable to its prior acquisition of Fabric Genomics, an AI-driven genomic interpretation company, which the Company had touted as expected to expand its addressable market through multiple scalable revenue streams and transform static data into a recurring revenue-generating platform. On this news, the price of GeneDx shares fell by $33.42 per share, or 49.2%. The case is *Basma v. GeneDx Holdings Corp.,* No. 26-cv-00880. About ClaimsFiler ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations. To learn more about ClaimsFiler, visit www.claimsfiler.com. ClaimsFiler (833) 538-3604 www.claimsfiler.com View original content to download multimedia:https://www.prnewswire.com/news-releases/genedx-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-genedx-holdings-corp---wgs-302834464.html SOURCE ClaimsFiler ### Related Stocks - [WGS.US](https://longbridge.com/en/quote/WGS.US.md) - [WGSWW.US](https://longbridge.com/en/quote/WGSWW.US.md) ## Related News & Research - [The Manufacturers Life Insurance Company Sells 12,820 Shares of GeneDx Holdings Corp. $WGS](https://longbridge.com/en/news/295906794.md) - [How Investors Are Reacting To GeneDx Holdings (WGS) Class Actions Over Fabric Impairment And Guidance Cut](https://longbridge.com/en/news/292370354.md) - [SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in GeneDx Holdings Corp. Lawsuit - WGS](https://longbridge.com/en/news/294379887.md) - [GeneDx Q2 revenue beats analyst estimates](https://longbridge.com/en/news/294732713.md) - [09:25 ETHub Group, Inc. (HUBG) Investors: August 28, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - Hagens Berman](https://longbridge.com/en/news/296499161.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**